Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Asker Healthcare Group ABOSTO:ASKER +1.91%13 3-Year ROIIC % is 3.94 as of Dec. 2025, which is at its 10-year median of 3.94. GuruFocus rates OSTO:ASKER with a GF Score™ of 13/100. The stock has 2 warning signs investors should review. Among 112 Medical Distribution companies, Asker Healthcare Group AB ranks better than 55.36% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Asker Healthcare Group AB's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 3.94%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Asker Healthcare Group AB's 3-Year ROIIC % or its related term are showing as below:
OSTO:ASKER's 3-Year ROIIC % is ranked better than 55.36% of 112
companies
in the Medical Distribution industry
Industry Median: 2.295
vs OSTO:ASKER: 3.94
Asker Healthcare Group AB (OSTO:ASKER) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Asker Healthcare Group AB 3-Year ROIIC % Related Terms
Asker Healthcare Group AB 3-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:ASKER vs MCK, CAH, COR: 3-Year ROIIC % Comparison
For the Medical Distribution subindustry, Asker Healthcare Group AB's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Asker Healthcare Group AB 3-Year ROIIC % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Asker Healthcare Group AB's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Asker Healthcare Group AB's 3-Year ROIIC % falls into.
Asker Healthcare Group AB 3-Year ROIIC % Calculation
Asker Healthcare Group AB's 3-Year ROIIC % for the quarter that ended in Dec. 2025 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( 772.3522 (Dec. 2025) - 562.4072 (Dec. 2022) )
/
( 14212 (Dec. 2025) - 8885 (Dec. 2022) )
=
209.945
/
5327
=
3.94%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Asker Healthcare Group AB (OSTO:ASKER) has a 3-Year ROIIC % of 3.94 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Asker Healthcare Group AB and its competitors. This is near median its historical median of 3.94. Over the past decade, Asker Healthcare Group AB's 3-Year ROIIC % has ranged from 3.94 to 3.94. According to the industry distribution chart, Asker Healthcare Group AB ranks #50 out of 112 companies in the Medical Distribution industry, placing it in the top 44.6%.
Is Asker Healthcare Group AB's 3-Year ROIIC % too high?
Asker Healthcare Group AB's current 3-Year ROIIC % of 3.94 is near median its 10-year median of 3.94. Over the past 10 years, this metric has ranged from a low of 3.94 to a high of 3.94. The Medical Distribution industry median 3-Year ROIIC % is 2.30. Asker Healthcare Group AB's value of 3.94 is 71.7% above this industry median. Based on the distribution chart, Asker Healthcare Group AB ranks #50 out of 112 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Asker Healthcare Group AB has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Asker Healthcare Group AB's 3-Year ROIIC % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Asker Healthcare Group AB ranks #50 out of 112 companies for 3-Year ROIIC %. This puts Asker Healthcare Group AB in the upper half of its industry. The industry median 3-Year ROIIC % is 2.30. Asker Healthcare Group AB's value of 3.94 is 71.7% above this benchmark. Historically, Asker Healthcare Group AB's own 3-Year ROIIC % has ranged from 3.94 to 3.94 over the past decade. While the company's 10-year median is 3.94 vs. the industry median of 2.30, Asker Healthcare Group AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Medical Distribution company?
The median 3-Year ROIIC % among Medical Distribution companies is 2.30, based on 112 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Asker Healthcare Group AB's current 3-Year ROIIC % of 3.94 is 71.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Asker Healthcare Group AB and its competitors. For the Medical Distribution industry, the median 3-Year ROIIC % is 2.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Asker Healthcare Group AB's current 3-Year ROIIC % is 3.94, which is near median its own 10-year median of 3.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asker Healthcare Group AB stock overvalued right now?
Asker Healthcare Group AB (OSTO:ASKER) has a current 3-Year ROIIC % of 3.94. The current 3-Year ROIIC % is 3.94, which is near median its 10-year median of 3.94 and 71.7% above the Medical Distribution industry median of 2.30. Asker Healthcare Group AB's overall GF Score™ is 13/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Asker Healthcare Group AB (OSTO:ASKER), the current 3-Year ROIIC % is 3.94 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Asker Healthcare Group AB is a provider of medical products and solutions that drive progress in the European healthcare sector. The company is engaged in building and acquiring companies to support the healthcare system to improve patient outcomes, reduce the total cost of care, and ensure a fair and sustainable value chain. The company also offers a range of value-added solutions to support its suppliers and customers in, for example, market access, efficiency, and sustainability. Company has adapted a twin engine growth strategy that combines organic and acquired growth. Geographically, the company evaluates the operations in three business areas: North, West and Central.
13GF Score
Get the complete analysis for OSTO:ASKER
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:ASKER has been successfully added to your 
